probenecid has been researched along with Hepatocellular Carcinoma in 3 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rius, M | 1 |
| Nies, AT | 1 |
| Hummel-Eisenbeiss, J | 1 |
| Jedlitschky, G | 1 |
| Keppler, D | 1 |
| Han, X | 1 |
| Yang, J | 1 |
| Li, D | 1 |
| Guo, Z | 1 |
| Ng, KH | 1 |
| Lim, BG | 1 |
| Wong, KP | 1 |
3 other studies available for probenecid and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Antibodies; Carcinoma, Hepatocellular; Cell Po | 2003 |
Overexpression of Uric Acid Transporter SLC2A9 Inhibits Proliferation of Hepatocellular Carcinoma Cells.
Topics: Apoptosis; Carcinogenesis; Carcinoma, Hepatocellular; Cell Proliferation; Gene Expression Regulation | 2019 |
Sulfate conjugating and transport functions of MDCK distal tubular cells.
Topics: Animals; Biological Transport; Buthionine Sulfoximine; Carcinoma, Hepatocellular; Cell Line, Tumor; | 2003 |